Abstract:Objective To explore the differential expressions of ovarian cancer stem cells (OCSC) markers CD133 and CD44 in primary and recurrent epithelial ovarian cancer (EOC) tissues and its significances.Methods From January 1,2003 to December 31,2016,a total of 15 patients with recurrent EOC,30 primary EOC patients with advanced stage who did not receive chemotherapy before surgery,and 30 primary EOC patients with advanced stage who received neoadjuvant chemotherapy (NACT) before surgery in West China Second University Hospital,Sichuan University were selected as research subjects,and they were included into the recurrent group (n=15),non-chemotherapy group (n =30),and NACT group (n=30).The positive expression rates and optical density (OD) of CD133 and CD44 in different types of EOC tissues were detected by immuohistochemistry.Paired chi-square test and Wilcoxon signed rank sum test were used to compare the positive expression rates and OD of CD133 and CD44 between EOC tissues of primary and recurrent surgery in recurrent group.Chi-square test and Wilcoxon rank sum test were used to compare the positive expression rates and OD of CD133 and CD44 between EOC tissues of non-chemotherapy group and NACT group.Correlation analysis of CD44 and CD133 expressions in EOC tissues was analyzed by Cramer's V coefficient.This study met the requirements of the World Medical Association Declaration of Helsinki revised in 2013.There were no significant differences in the general clinical data of age,pathological type and grade between the three groups (P＞0.05).Results ①In recurrent group,there were no statistical differences between EOC tissues of primary and recurrent surgery in positive expression rates of CD133,and OD of CD133 and CD44 (P＞0.05).The positive expression rate of CD44 in EOC tissues of recurrent surgery was 86.7％ (13/15),which was higher than that in primary surgery [73.3％ (11/15)],and the difference was statistically significant (x2 =4.922,P=0.027).②The OD of CD133 and CD44,and the positive expression rate of CD44 in EOC tissues of NACT group all were higher than those of non-chemotherapy group,and all the differences were statistically significant (Z=-2.176,P=0.030;x2 =5.455,P=0.020;Z=-4.759,P＜0.001).③There was correlation between the expressions of CD133 and CD44 in EOC tissues (Cramer's V=0.462,P＜0.001).Conclusions The OCSC markers CD133 and CD44 are co-expressed in EOC tissues and may co-exist on the surface of OCSC.The residue of OCSC after chemotherapy may be the real cause of EOC recurrence.

Expressions of OCT4, Notch1 and DLL4 and Their Clinical Implications in Epithelial Ovarian Cancer

Expression and clinical significance of P16, P15,and VEGF proteins in primary epithelial ovarian carcinoma

Expression of Octamer-4 in Serous and Mucinous Ovarian Carcinoma.

CDK1 as a Novel Potential Biomarker for Predicting the Prognosis of endometrioid ovarian carcinoma

Expressions of IGF1,IGF1R,IGFBP3 and their relationship with biological behavior of epithelial ovarian cancer

Expression of CD44 and NANOG in epithelial ovarian cancer and its clin-ical significance

Co-expression of CD44/MyD88 is a Poor Prognostic Factor in Advanced Epithelial Ovarian Cancer

The Correlation of the Expressions of WWOX, LGR5 and Vasohibin-1 in Epithelial Ovarian Cancer and Their Clinical Significance.

Overexpression of CD 44 and EpCAM may be associated with the initiation and progression of epithelial ovarian cancer

Expressions of P73 Protein,p21~(waf1/cip1) Protein and PCNA Protein in Epithelial Ovarian Cancer and Their Correlation

The Expression of VEGF and Dll4/Notch Pathway Molecules in Ovarian Cancer

[Expressions of OCT4 and CD133 and Their Correlation in Colonic Cancer].

Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer

Expressions of CD133 and CD44 in Primary and Recurrent Epithelial Ovarian Cancer Tissues

The expression and clinicopathological significance of E-cadherin,β-catenin and p120 in epithelial ovarian carcinoma

CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer

[Relationship Between Expressions of P53, C-Erbb2 Genes, Proliferating Cell Nuclear Antigen and Prognosis of Patients with Ovarian Epithelial Carcinoma].

Expression of Clinical Significance of p110α, hvps34 and p-PKB in Epithelial Ovarian Cancer

Expression and significance of the TLR4/MyD88 signaling pathway in ovarian epithelial cancers

Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer.

Expressions of Lysophosphatidic Acid Receptors in the Development of Human Ovarian Carcinoma.